PharmaShots | Incisive News in 3 Shots

Subscribe Now

kevzara

Insights+: The US FDA New Drug Approvals in March 2023

Insights+: The US FDA New Drug Approvals in March 2023

April 19, 2023

Sanofi and Regeneron's Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US

Sanofi and Regeneron's Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US

July 3, 2020

Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US

Sanofi and Regeneron Expand Clinical Program of Kevzara (sarilumab) for the Treatment of COVID-19 Outside the US

March 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us